MedPath

To study the effect of perioperative blood transfusion on functional outcome after brain tumor surgery

Not Applicable
Conditions
Health Condition 1: D320- Benign neoplasm of cerebral meninges
Registration Number
CTRI/2021/12/038540
Lead Sponsor
Dr Nidhi Singh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Adult patients of either sex, aged 18 to 65 years.

2. Patients belonging to the American Society of Anesthesiologists (ASA) Grade 1 and 2.

3. Patients scheduled for transcranial craniotomy for meningioma excision.

Exclusion Criteria

1.Any patient/guardian refusing to provide consent to participate in the study

2.Loss to follow up of the patients for 3 months.

3.Patients with a history of blood transfusion within the last three months.

4.Patients with pre-existing significant systemic diseases like hepatic or renal diseases, leukemias, etc.

5.Patients with significant coagulopathies or hematological abnormality, those on anticoagulants, or with deranged International Normalised Ratio (INR).

6.Patients with recurrent tumors posted for re-do surgery.

7.Patients with a history of embolization

8.Patients posted for endoscopic excision of the tumor

9.ASA grade 3 and 4 patients

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath